| <3 | 158 (32.2%) | 139 (33.1%) | 19 (26.8%) | |
| ≥3 | 333 (67.8%) | 281 (66.9%) | 52 (73.2%) | |
| 现症吸烟史 | 329 (67.0%) | 278 (66.2%) | 51 (71.8%) | 0.350 |
| 饮酒史 | 322 (65.6%) | 273 (65.0%) | 49 (69.0%) | 0.510 |
| ASA |
| 0.607 | ||
| I | 233 (47.5%) | 203 (48.3%) | 30 (42.3%) | |
| II | 224 (45.6%) | 189 (45.0%) | 35 (49.3%) | |
| III | 34 (6.9%) | 28 (6.7%) | 6 (8.4%) | |
| 糖尿病病史 | 37 (7.5%) | 29 (6.9%) | 8 (11.3%) | 0.198 |
| 高血压病史 | 122 (24.8%) | 101 (24.1%) | 21 (29.6%) | 0.319 |
| 心脏病病史 | 35 (7.1%) | 28 (6.7%) | 7 (9.9%) | 0.334 |
| 慢性阻塞性肺疾病病史 | 25 (5.1%) | 15 (3.6%) | 10 (14.1%) | <0.001* |
| 肿瘤位置 |
| 0.263 | ||
| 颈段 | 5 (1.0%) | 4 (1.0%) | 1 (1.4%) | |
| 胸上段 | 51 (10.4%) | 44 (10.5%) | 7 (9.9%) | |
| 胸中段 | 79 (16.1%) | 72 (17.1%) | 7 (9.9%) | |
| 胸下段 | 284 (57.8%) | 235 (55.9%) | 49 (69.0%) | |
| 胃食管交界部 | 72 (14.7%) | 65 (15.5%) | 7 (9.8%) | |
| 病理类型 |
| 0.868 | ||
| 鳞癌 | 387 (78.8%) | 331 (78.8%) | 56 (78.9%) | |
| 腺癌 | 93 (18.9%) | 79 (18.8%) | 14 (19.7%) | |
| 其他类型 | 11 (2.2%) | 10 (2.4%) | 1 (1.4%) | |
| 新辅助治疗 | 31 (6.3%) | 27 (6.43%) | 4 (5.63%) | 0.799 |
| 手术方式 |
| 0.184 | ||
| Sweet | 207 (42.2%) | 170 (40.5%) | 37 (52.1%) | |
| IvorLewis | 203 (41.3%) | 179 (42.6%) | 24 (33.8%) | |
| Mackeown | 81 (16.5%) | 71 (16.9%) | 10 (14.1%) | |
| 开放/微创/杂交 |
| 0.108 | ||
| 开放 | 283 (57.6%) | 237 (56.4%) | 46 (64.8%) | |
| 微创 | 148 (30.1%) | 134 (31.9%) | 14 (19.7%) | |
| 杂交 | 60 (12.2%) | 49 (11.7%) | 11 (15.5%) | |
| 胸部手术方式 |
| 0.032* | ||
| 开放 | 341 (69.5%) | 284 (67.6%) | 57 (80.3%) | |
| 微创 | 150 (30.5%) | 136 (32.4%) | 14 (19.7%) | |
| 手术时间.分钟 | 285.0 (234.0~355.0) | 285.0 (230.0~356.5) | 290.0 (247.5~352.5) | 0.437 |